Effects of dietary n-3 PUFA levels in early life on susceptibility to high-fat-diet-induced metabolic syndrome in adult mice

J Nutr Biochem. 2021 Mar:89:108578. doi: 10.1016/j.jnutbio.2020.108578. Epub 2020 Dec 31.

Abstract

The maternal nutritional status during pregnancy and lactation was closely related to the growth and development of the fetus and infants, which had a profound impact on the health of the offspring. N-3 polyunsaturated fatty acid (PUFA) had been proved to have beneficial effects on glucolipid metabolism. However, the effects of dietary different n-3 PUFA levels for mother during pregnancy and lactation on susceptibility to high-fat-diet-induced metabolic syndrome for offspring in adulthood are still unclear. The maternal mice were fed with control, n-3 PUFA-deficient or fish oil-contained n-3 PUFA-rich diets during pregnancy and lactation, and the weaned offspring were fed with high-fat or low-fat diet for 13 weeks, then were subjected to oral glucose tolerance tests. The results showed that dietary n-3 PUFA-deficiency in early life could aggravate the high-fat-diet-induced glucolipid metabolism disorders, including glucose intolerance, insulin resistance, obesity, and dyslipidemia, thus increased the susceptibility to metabolic syndrome of adult mice. Notably, nutritional supplementation with n-3 PUFA in early life could significantly alleviate the glucose metabolism disorders by increasing insulin sensitivity, inhibiting gluconeogenesis and promoting glycogenesis. In addition, administration with n-3 PUFA in early life remarkably reduced serum and hepatic lipid profiles by mediating the expression of genes related to lipogenesis and β-oxidation of fatty acids. Dietary n-3 PUFA-deficiency in early life increases the susceptibility to metabolic syndrome of adult offspring, and nutritional supplementation with n-3 PUFA enhances the tolerance to a high-fat diet of adult offspring.

Keywords: early life; glycolipid metabolism; insulin resistance; metabolic syndrome; n-3 PUFA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet, Fat-Restricted
  • Diet, High-Fat / adverse effects*
  • Dietary Supplements
  • Dyslipidemias / etiology
  • Dyslipidemias / prevention & control
  • Fatty Acids, Omega-3 / pharmacology*
  • Female
  • Fish Oils / pharmacology
  • Glucose Intolerance / metabolism
  • Glucose Tolerance Test
  • Insulin Resistance
  • Lactation / metabolism
  • Lipid Metabolism
  • Lipids / blood
  • Lipogenesis
  • Liver / metabolism
  • Male
  • Maternal Nutritional Physiological Phenomena*
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / pathology
  • Metabolic Syndrome / prevention & control*
  • Mice
  • Mice, Inbred C57BL
  • Obesity / etiology
  • Obesity / prevention & control
  • Pregnancy

Substances

  • Fatty Acids, Omega-3
  • Fish Oils
  • Lipids